Clinical Trial Update: Radiation Post-CAR T in Refractory Lymphoma [NA]

View source ↗

Summary

A clinical trial evaluating radiation after CAR T therapy in refractory lymphoma was terminated. Results were posted on 2024-04-10.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hematologic Malignancy, Refractory Lymphoma | NA | Status: TERMINATED | Results posted: 2024-04-10